Literature DB >> 30614192

Immune dysregulation and Th2 polarization are associated with atopic dermatitis in heart-transplant children: A delicate balance between risk of rejection or atopic symptoms.

Jacobo López-Abente1, Esther Bernaldo-de-Quirós1, Manuela Camino2, Nuria Gil2, Esther Panadero2, Minia Campos-Domínguez1,3, Elena Seoane-Reula1,4, Juan M Gil-Jaurena5, Marjorie Pion1, Rafael Correa-Rocha1,6.   

Abstract

Atopic dermatitis (AD) has a high incidence in heart-transplant children, and the reason why there is more AD after transplantation is still unknown. We conducted a cross-sectional study comparing 11 AD and 11 non-AD age-matched heart-transplant children, to assess which immune alterations are related to AD in these patients. AD patients had been transplanted at a younger age compared to non-AD, indicating that age at transplant may be determinant in the onset of AD. The earlier thymectomy in AD heart-transplant children favored the presence of more differentiated phenotypes in the T cell compartment. We observed a clear reduction in the T-helper 1/T-helper 2 (Th1/Th2) ratio in AD children. This Th2 polarization was related to eosinophilia and high immunoglobulin E levels, but also to an impaired regulatory T cell (Treg) suppression, which could be secondary to an exhaustion of the Treg compartment. Interestingly, AD patients were free of rejection episodes (0/11) in comparison to non-AD children (4/11). We propose that a predominant Th2 phenotype may prevent the emergence of Th1 responses associated with graft rejection. A more differentiated Treg phenotype could also play a role in preventing acute rejection in the first year posttransplant. Our findings provide useful insights and knowledge for the better understanding of atopic disorders in transplanted children.
© 2019 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  T cell biology; allergy; clinical research/practice; comorbidities; heart transplantation/cardiology; immune regulation; immunobiology; pediatrics; thymus/thymic biology; translational research/science

Year:  2019        PMID: 30614192     DOI: 10.1111/ajt.15245

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  4 in total

1.  A Novel GMP Protocol to Produce High-Quality Treg Cells From the Pediatric Thymic Tissue to Be Employed as Cellular Therapy.

Authors:  Esther Bernaldo-de-Quirós; Beatriz Cózar; Rocío López-Esteban; Maribel Clemente; Juan Miguel Gil-Jaurena; Carlos Pardo; Ana Pita; Ramón Pérez-Caballero; Manuela Camino; Nuria Gil; María Eugenia Fernández-Santos; Susana Suarez; Marjorie Pion; Marta Martínez-Bonet; Rafael Correa-Rocha
Journal:  Front Immunol       Date:  2022-05-16       Impact factor: 8.786

Review 2.  Solving the Conundrum of Eosinophils in Alloimmunity.

Authors:  Cherie Alissa Lynch; Yizhan Guo; Zhongcheng Mei; Daniel Kreisel; Andrew E Gelman; Elizabeth A Jacobsen; Alexander Sasha Krupnick
Journal:  Transplantation       Date:  2021-12-27       Impact factor: 5.385

3.  Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation.

Authors:  Jacobo López-Abente; Marta Martínez-Bonet; Esther Bernaldo-de-Quirós; Manuela Camino; Nuria Gil; Esther Panadero; Juan Miguel Gil-Jaurena; Maribel Clemente; Simon Urschel; Lori West; Marjorie Pion; Rafael Correa-Rocha
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

4.  The Presence of a Marked Imbalance Between Regulatory T Cells and Effector T Cells Reveals That Tolerance Mechanisms Could Be Compromised in Heart Transplant Children.

Authors:  Esther Bernaldo-de-Quirós; Jacobo López-Abente; Manuela Camino; Nuria Gil; Esther Panadero; Rocío López-Esteban; Marta Martínez-Bonet; Marjorie Pion; Rafael Correa-Rocha
Journal:  Transplant Direct       Date:  2021-04-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.